Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q1

2796.TEDINET S100PCXQ
Period2022-06-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥12.9bn2022-06-01 → 2022-08-31Cons.Net sales
Revenue¥51.6bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥13.1bn2021-06-01 → 2021-08-31Cons.Net sales
Operating income¥348m2022-06-01 → 2022-08-31Cons.Operating income
Operating income¥317m2021-06-01 → 2021-08-31Cons.Operating income
Ordinary income¥341m2022-06-01 → 2022-08-31Cons.Ordinary income
Ordinary income¥1.5bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥335m2021-06-01 → 2021-08-31Cons.Ordinary income
Profit before tax¥318m2022-06-01 → 2022-08-31Cons.Income before income taxes
Profit before tax¥293m2021-06-01 → 2021-08-31Cons.Income before income taxes
Net income (owners)¥111m2022-06-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥447m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥63m2021-06-01 → 2021-08-31Cons.Profit loss attributable to owners of parent
Net income¥114m2022-06-01 → 2022-08-31Cons.Profit loss
Net income¥62m2021-06-01 → 2021-08-31Cons.Profit loss
Total assets¥23.2bnat 2022-08-31Cons.Assets
Total assets¥23.7bnat 2022-05-31Cons.Assets
Total assets¥23.6bnat 2021-08-31Cons.Total assets (5-year summary)
Total liabilities¥16.5bnat 2022-08-31Cons.Liabilities
Total liabilities¥17.0bnat 2022-05-31Cons.Liabilities
Net assets / equity¥6.7bnat 2022-08-31Cons.Net assets
Net assets / equity¥6.7bnat 2022-05-31Cons.Net assets
Net assets / equity¥6.3bnat 2021-08-31Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2022-08-31Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
EPS (basic)¥11.882022-06-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.992021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥6.832021-06-01 → 2021-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥8.992022-06-01 → 2022-08-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.292021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥5.182021-06-01 → 2021-08-31Cons.Diluted earnings per share (5-year summary)
Equity ratio27.6%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.9%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio25.2%at 2021-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2022-08-31¥204m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2022-08-31¥204m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2022-08-31¥21m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-08-31−¥75m
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2022-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2022-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2022-08-31−¥35m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2022-08-31¥169m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2022-08-31¥169m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2022-08-31¥20m
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2022-08-31¥10.4bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2022-08-31¥10.4bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2022-08-31¥398m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2022-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2022-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2022-08-31¥19m
—segment totalrevenue2022-06-01 → 2022-08-31¥12.7bn
—segment totalrevenue external2022-06-01 → 2022-08-31¥12.7bn
—segment totalsegment profit2022-06-01 → 2022-08-31¥402m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-08-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-08-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-08-31¥424m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-06-01 → 2021-08-31¥273m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-06-01 → 2021-08-31¥273m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-06-01 → 2021-08-31−¥8m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-08-31−¥73m
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2021-06-01 → 2021-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2021-06-01 → 2021-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2021-06-01 → 2021-08-31−¥14m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2021-06-01 → 2021-08-31¥163m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2021-06-01 → 2021-08-31¥163m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2021-06-01 → 2021-08-31¥21m
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue2021-06-01 → 2021-08-31¥10.5bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2021-06-01 → 2021-08-31¥10.5bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2021-06-01 → 2021-08-31¥377m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue2021-06-01 → 2021-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue external2021-06-01 → 2021-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentsegment profit2021-06-01 → 2021-08-31¥14m
—segment totalrevenue2021-06-01 → 2021-08-31¥12.8bn
—segment totalrevenue external2021-06-01 → 2021-08-31¥12.8bn
—segment totalsegment profit2021-06-01 → 2021-08-31¥399m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-08-31¥13.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-08-31¥13.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-08-31¥391m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 379
ItemContextValueUnit
Profit lossPrior1YTDDuration62000000JPY
Profit lossCurrentYTDDuration114000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-0JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration3000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration63000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration111000000JPY
Profit lossPrior1YTDDuration62000000JPY
Profit lossCurrentYTDDuration114000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration0JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration0JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-0JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-0JPY
Other comprehensive incomePrior1YTDDuration-0JPY
Other comprehensive incomeCurrentYTDDuration-0JPY
Comprehensive incomePrior1YTDDuration62000000JPY
Comprehensive incomeCurrentYTDDuration114000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration63000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration110000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-0JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration3000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05379-000DispensingPharmacyReportableSegmentsMember10514000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember1984000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember163000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05379-000MedicalMallReportableSegmentsMember126000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember12789000000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember273000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember13062000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration13062000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E05379-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E05379-000MedicalMallReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05379-000DispensingPharmacyReportableSegmentsMember10514000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember1984000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember163000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05379-000MedicalMallReportableSegmentsMember126000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember12789000000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember273000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember13062000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration13062000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E05379-000DispensingPharmacyReportableSegmentsMember377000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember-14000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember21000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2022-08-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-08-31pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-08-31pass
statement vs summary · revenueconsolidated 2021-06-01/2021-08-31pass
statement vs summary · revenueconsolidated 2022-06-01/2022-08-31pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-08-31pass